SAR445877

Clinical trials for SAR445877 explained in plain language.

Never miss a new study

Get alerted when new SAR445877 trials appear

Sign up with your email to follow new studies for SAR445877, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New hope for hard-to-treat colon cancer? early trial combines three drugs

Disease control Not yet recruiting

This early-phase study tests whether adding a new drug called SAR445877 to standard chemotherapy (FOLFOX6) and a targeted therapy (bevacizumab) is safe for people with a specific type of advanced colorectal cancer that hasn't spread yet. About 41 adults with microsatellite stable…

Matched conditions: SAR445877

Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Apr 26, 2026 20:03 UTC

SAR445877

Get alerted when new SAR445877 trials appear

New hope for hard-to-treat colon cancer? early trial combines three drugs